| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/17/2012 | US8097431 Methods and compositions for detecting steroids |
| 01/17/2012 | US8097410 identifying a human subject having increased or decreased sensitivity to warfarin, by detecting the presence of a single nucleotide polymorphism in the vitamin K epoxide reductase (VKOR) gene |
| 01/17/2012 | US8097408 Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases |
| 01/17/2012 | US8097405 Nucleic acid sequencing processes using non-radioactive detectable modified or labeled nucleotides or nucleotide analogs, and other processes for nucleic acid detection and chromosomal characterization using such non-radioactive detectable modified or labeled nucleotides or nucleotide analogs |
| 01/17/2012 | US8097277 Charge-dynamic polymers and delivery of anionic compounds |
| 01/17/2012 | US8097257 MAGE3 polypeptides |
| 01/17/2012 | US8097255 Mammalian receptor protein DCRS5; methods of treatment |
| 01/17/2012 | US8097247 Probiotic, lactic acid-producing bacteria and uses thereof |
| 01/17/2012 | US8097243 Microparticle-based transfection and activation of dendritic cells |
| 01/17/2012 | CA2604357C P-cadherin antibodies |
| 01/17/2012 | CA2583009C Ubiquitin or gamma-crystalline conjugates for use in therapy, diagnosis and chromatography |
| 01/17/2012 | CA2489016C Method of expressing recombinant protein in cho cells |
| 01/17/2012 | CA2482440C Oligomeric compounds having modified phosphate groups |
| 01/17/2012 | CA2465007C Methods and means for producing proteins with predetermined post-translational modifications |
| 01/17/2012 | CA2461917C Isolated dna molecules encoding humanized calcitonin gene-related peptide receptor, related non-human transgenic animals and assay methods |
| 01/17/2012 | CA2461915C Isolation and cultivation of microorganisms from natural environments and drug discovery based thereon |
| 01/17/2012 | CA2457362C Human monoclonal rabies virus neutralizing antibodies, and methods for making and using the same |
| 01/17/2012 | CA2451353C Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer |
| 01/17/2012 | CA2446390C Antigenic epitopes of factor viii, inhibitors directed against said epitopes and use thereof |
| 01/17/2012 | CA2441958C Il-28 polypeptides and polynucleotids |
| 01/17/2012 | CA2427916C Surface transfection and expression procedure |
| 01/17/2012 | CA2414542C Method for introducing nucleic acids and other biologically active molecules into the nucleus of higher eukaryotic cells using electric current |
| 01/17/2012 | CA2413195C Ligand to gpr8 and dna thereof |
| 01/17/2012 | CA2402117C Chimeric animal model susceptible to human hepatitis c virus infection |
| 01/17/2012 | CA2345208C Protective recombinant haemophilus influenzae high molecular weight proteins |
| 01/17/2012 | CA2292893C Plant artificial chromosome (plac) compositions and methods |
| 01/17/2012 | CA2264191C Recombinant toxin fragments |
| 01/17/2012 | CA2194478C Gene coding for the e1 endoglucanase |
| 01/12/2012 | WO2012006623A1 Systems for factor viii processing and methods thereof |
| 01/12/2012 | WO2012006622A2 Improved agronomic traits via genetically induced elevation of phytohormone levels in plants |
| 01/12/2012 | WO2012006577A2 Direct reprogramming of cells to cardiac myocyte fate |
| 01/12/2012 | WO2012006551A2 Neuroprotective molecules and methods of treating neurological disorders and inducing stress granules |
| 01/12/2012 | WO2012006542A2 Method of detecting single nucleotide polymorphisms |
| 01/12/2012 | WO2012006506A1 Metabolic gene, enzyme, and flux targets for cancer therapy |
| 01/12/2012 | WO2012006500A2 Monoclonal antibodies against hepatitis c virus core protein |
| 01/12/2012 | WO2012006490A2 Dual variable domain immunoglobulins and uses thereof |
| 01/12/2012 | WO2012006447A2 Gene signatures for cancer prognosis |
| 01/12/2012 | WO2012006443A2 Linear dna molecule delivery using pegylated quantum dots for stable transformation in plants |
| 01/12/2012 | WO2012006440A2 Endothelial cell production by programming |
| 01/12/2012 | WO2012006439A2 Production of functionalized linear dna cassette and quantum dot/nanoparticle mediated delivery in plants |
| 01/12/2012 | WO2012006437A2 Polypeptides having antiviral activity and methods for use thereof |
| 01/12/2012 | WO2012006378A1 Liposomes with lipids having an advantageous pka- value for rna delivery |
| 01/12/2012 | WO2012006372A1 Delivery of rna to different cell types |
| 01/12/2012 | WO2012006359A1 Delivery of self-replicating rna using biodegradable polymer particles |
| 01/12/2012 | WO2012006329A2 Apoe4 and apoj biomarker-based prevention and treatment of dementia |
| 01/12/2012 | WO2012006302A1 Cultivation of green algae chlorococcum pamirum for production of biofuel |
| 01/12/2012 | WO2012006271A1 Control of coleopteran insect pests |
| 01/12/2012 | WO2012006244A1 Method for producing phloroglucinol and dihydrophloroglucinol |
| 01/12/2012 | WO2012006220A1 Treatment of avian species with inhibitors of p110 delta signaling |
| 01/12/2012 | WO2012006180A1 Hiv immunogens |
| 01/12/2012 | WO2012006145A2 Com positions and methods for retargeting virus constructs |
| 01/12/2012 | WO2012006027A1 Fzd8 extracellular domains and fzd8 extracellular domain fusion molecules and treatments using same |
| 01/12/2012 | WO2012005982A2 Reporter for rna polymerase ii termination |
| 01/12/2012 | WO2012005591A1 A plant heat-resistance gene jaz5a and use thereof |
| 01/12/2012 | WO2012005590A1 A plant heat-resistance gene bccdreb2a and use thereof |
| 01/12/2012 | WO2012005589A1 A plant heat-resistance gene hsf1 and use thereof |
| 01/12/2012 | WO2012005578A1 Bacterial surface display and screening of thioether-bridge-containing peptides |
| 01/12/2012 | WO2012005572A1 Mirna and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated braf pathway |
| 01/12/2012 | WO2012005529A2 Transgenic mice expressing human ferritin in a manner non-specific to tissue, and use thereof |
| 01/12/2012 | WO2012005393A1 Natural killer cell receptor genotyping method using multiple gene amplification |
| 01/12/2012 | WO2012005383A2 Method for production of tumor cells from normal mammary epithelial cells |
| 01/12/2012 | WO2012005379A1 Transformant obtained by introducing gm1 gene and crmp2 gene |
| 01/12/2012 | WO2012005378A2 Dna element having the activity of enhancing foreign gene expression |
| 01/12/2012 | WO2012005372A1 PROCESS FOR PRODUCING SULFUR-CONTAINING α-AMINO ACID COMPOUND |
| 01/12/2012 | WO2012005368A1 Single-strand nucleic acid molecule for controlling gene expression |
| 01/12/2012 | WO2012005328A1 Antibody capable of binding to lysophosphatidylglucoside, and composition containing the antibody |
| 01/12/2012 | WO2012005138A1 Organism data processing method and device, storage medium and program |
| 01/12/2012 | WO2012004795A1 Transgenic plants having altered dahp synthase activity |
| 01/12/2012 | WO2012004790A2 Nucleic acid aptamer-based diagnostic methods with novel techniques for signal enhancement |
| 01/12/2012 | WO2012004645A1 A RECOMBINANT VACCINE AGAINST CLOSTRIDIUM PERFRINGENS INFECTION AND EPSILON (ε) TOXIN INTOXICATION |
| 01/12/2012 | WO2012004619A1 Procedure for the specific isolation of total dna content of bacterial germs and a kit for this purpose |
| 01/12/2012 | WO2012004437A1 Novel serine protease inhibitor and use thereof |
| 01/12/2012 | WO2012004401A2 Preformed defense in plants |
| 01/12/2012 | WO2012004346A1 Genetically engineered stem cells, method of production and uses thereof |
| 01/12/2012 | WO2012004322A1 A transgenic animal as a model for identifying adult stem cells, and uses thereof |
| 01/12/2012 | WO2012004226A1 Production cell line |
| 01/12/2012 | WO2012004204A1 Synthesis of chemical libraries |
| 01/12/2012 | WO2012004013A2 Glucosinolate transporter protein and uses thereof |
| 01/12/2012 | WO2012003545A1 Acetylenation of fatty acids |
| 01/12/2012 | WO2011145629A3 ANTIBODY CAPABLE OF BINDING TO TRANSFORMING GROWTH FACTOR ALPHA AND HAVING ANTIPROLIFERATIVE ACTIVITY ON CANCER HAVING Ras GENE MUTATION |
| 01/12/2012 | WO2011133584A3 Nucleic acid compounds for inhibiting hras gene expression and uses thereof |
| 01/12/2012 | WO2011132977A3 Pcr device including two heating blocks |
| 01/12/2012 | WO2011130426A3 Compositions and methods for treatment of melanoma |
| 01/12/2012 | WO2011123842A9 Methods for treating parkinson's disease and other disorders of dopaminergic neurons of the brain |
| 01/12/2012 | WO2011117258A3 Methods of increasing efficiency of vector penetration of target tissue |
| 01/12/2012 | WO2011115439A3 Microorganism with improved production of 5'-xanthosine monophosphate and 5'-guanine monophosphate, and production method of 5'-xanthosine monophosphate and 5'-guanine monophosphate using same |
| 01/12/2012 | WO2011111501A9 Rna containing nucleoside compound, method for controlling amount of protein production from that rna and nucleoside compound |
| 01/12/2012 | WO2011109556A3 Method for producing soluble recombinant interferon protein without denaturing |
| 01/12/2012 | WO2011108854A3 Method for detecting nucleic acids by promoting branched dna complex formation |
| 01/12/2012 | WO2011106576A3 Methods and compositions for enhanced enzyme activity in fermenting microorganisms |
| 01/12/2012 | WO2011106356A3 Diagnositic methods of tumor suspectibility with single nucleotide polymorphisms inside microrna target sites |
| 01/12/2012 | WO2011105826A3 Method using camp expression measurement to diagnose prostate inflammation, and diagnostic kit |
| 01/12/2012 | WO2011105732A3 Method and kit for detecting egfr mutation by using pna-based real-time pcr clamping |
| 01/12/2012 | WO2011103502A3 Materials and methods for profiling micrornas |
| 01/12/2012 | WO2011103394A3 Methods for gene inhibition |
| 01/12/2012 | WO2011103248A3 AXMI221z, AXMI222z, AXMI223z, AXMI224z, AND AXMI225z DELTA-ENDOTOXIN GENES AND METHODS FOR THEIR USE |
| 01/12/2012 | WO2011103159A3 Assay for detecting closely- related serotypes of human papillomavirus (hpv) |
| 01/12/2012 | WO2011100650A9 Improved compositions and methods for pathogen control in plants |
| 01/12/2012 | WO2011073956A3 Heterologous hosts |
| 01/12/2012 | WO2011066304A3 Engineered beta-class carbonic anhydrase polypeptides and uses thereof |